Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study

NCT01567956 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

150

Enrollment

INDUSTRY

Sponsor class

Stopped Evidence of very low probability to success. No safety issues

Conditions

Ulcerative Colitis

Interventions

DRUG: Propionyl-L-Carnitine
DRUG: Placebo

Sponsor

sigma-tau i.f.r. S.p.A.

Collaborators

[object Object]